An Extraordinary General Meeting of Targovax ASA will be held at the Company’s offices at Lysaker, on 30 November 2017 at 13:00 CET.
Please find the notice including agenda for the Extraordinary General Meeting and appendices attached to this disclosure. The notice will also be sent to all shareholders. The notice and appendices will also be made available on Targovax’ website www.targovax.com under Corporate Governance and General Meetings.
Notice of attendance must be received no later than 29 November 2017 at 16:00 CET.
For further information, please contact:
Renate Birkeli, Investor Relations
Phone: +47 922 61 624
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.